Palace: Ilocos Norte under MECQ from Sept. 7-30 | Inquirer News

Palace: Ilocos Norte under MECQ from Sept. 7-30

By: - Reporter / @KAguilarINQ
/ 01:28 PM September 07, 2021

Ilocos Norte’s status has been reclassified to MECQ starting September 7 to 30 instead of GCQ as initially announced, Malacañang said. 

ilocos norte

MANILA, Philippines — Ilocos Norte’s status has been reclassified to modified enhanced community quarantine (MECQ) starting September 7 to 30 instead of general community quarantine (GCQ) with heightened restrictions initially announced, Malacañang said Tuesday.

“Ang Ilocos Norte po ay nasa MECQ mula September 7 hanggang 30. Ang naunang classification po ng Ilocos Norte ay GCQ with heightened restrictions,” presidential spokesperson Harry Roque said in a press briefing.

Article continues after this advertisement

(Ilocos Norte is under MECQ from September 7 to 30. Its initial classification was GCQ with heightened restrictions.)

FEATURED STORIES

The province has been under MECQ, the second strictest classification, since August 16 to curb coronavirus transmission.

Its average weekly COVID-19 cases has dropped to 144 from August 27 to September 3 compared to the 210 cases recorded the previous week.

Article continues after this advertisement

Ilocos Norte has 2,498 active COVID-19 cases as of September. 6.

Article continues after this advertisement

RELATED STORY:

Metro Manila to be under GCQ from Sept. 8-30, to pilot shift to granular lockdowns 

JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Ilocos Norte, MECQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.